These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17294451)

  • 21. Circulating KL-6/MUC1 as an independent predictor for disseminated intravascular coagulation in acute respiratory distress syndrome.
    Nakashima T; Yokoyama A; Ohnishi H; Hamada H; Ishikawa N; Haruta Y; Hattori N; Tanigawa K; Kohno N
    J Intern Med; 2008 Apr; 263(4):432-9. PubMed ID: 18298483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific detection of sialyl Lewis X determinant carried on the mucin GlcNAcbeta1-->6GalNAcalpha core structure as a tumor-associated antigen.
    Kumamoto K; Mitsuoka C; Izawa M; Kimura N; Otsubo N; Ishida H; Kiso M; Yamada T; Hirohashi S; Kannagi R
    Biochem Biophys Res Commun; 1998 Jun; 247(2):514-7. PubMed ID: 9642161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MUC1 in lung adenocarcinoma: cross-sectional genetic and serological study.
    Horimasu Y; Ishikawa N; Tanaka S; Hirano C; Iwamoto H; Ohshimo S; Fujitaka K; Hamada H; Hattori N; Kohno N
    BMC Cancer; 2017 Apr; 17(1):263. PubMed ID: 28403862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative serum CYFRA 21-1 level as a prognostic factor in surgically treated adenocarcinoma of lung.
    Park SY; Lee JG; Kim J; Park Y; Lee SK; Bae MK; Lee CY; Kim DJ; Chung KY
    Lung Cancer; 2013 Feb; 79(2):156-60. PubMed ID: 23206831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KL-6, a human MUC1 mucin, promotes proliferation and survival of lung fibroblasts.
    Ohshimo S; Yokoyama A; Hattori N; Ishikawa N; Hirasawa Y; Kohno N
    Biochem Biophys Res Commun; 2005 Dec; 338(4):1845-52. PubMed ID: 16289035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of a novel lung adenocarcinoma--associated serum antigen defined by two monoclonal antibodies, KM 432 and KM 227.
    Shitara K; Hanai N; Yoshida H
    Anticancer Res; 1993; 13(3):579-86. PubMed ID: 7686360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative serum levels of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens as prognostic markers after curative resection for colorectal cancer.
    Nakagoe T; Sawai T; Tsuji T; Jibiki MA; Nanashima A; Yamaguchi H; Yasutake T; Kurosaki N; Ayabe H; Arisawa K
    Cancer Detect Prev; 2001; 25(3):299-308. PubMed ID: 11425272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High serum concentrations of Sialyl Lewisx predict multilevel N2 disease in non-small-cell lung cancer.
    Mizuguchi S; Inoue K; Iwata T; Nishida T; Izumi N; Tsukioka T; Nishiyama N; Uenishi T; Suehiro S
    Ann Surg Oncol; 2006 Jul; 13(7):1010-8. PubMed ID: 16788764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphism of the MUC1 mucin gene is associated with susceptibility to lung adenocarcinoma and poor prognosis.
    Mitsuta K; Yokoyama A; Kondo K; Nakajima M; Arita K; Kohno N
    Oncol Rep; 2005 Jul; 14(1):185-9. PubMed ID: 15944787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct sub-populations of carcinoma-associated MUC1 mucins as detected by the monoclonal antibody 9H8 and antibodies against the sialyl-Lewis a and sialyl-Lewis x epitopes in the circulation of breast-cancer patients.
    Sikut R; Zhang K; Baeckström D; Hansson GC
    Int J Cancer; 1996 May; 66(5):617-23. PubMed ID: 8647622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis.
    Takahashi T; Munakata M; Suzuki I; Kawakami Y
    Am J Respir Crit Care Med; 1998 Oct; 158(4):1294-8. PubMed ID: 9769294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.
    Utsunomiya T; Yonezawa S; Sakamoto H; Kitamura H; Hokita S; Aiko T; Tanaka S; Irimura T; Kim YS; Sato E
    Clin Cancer Res; 1998 Nov; 4(11):2605-14. PubMed ID: 9829723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of a circulating tumor-associated antigen with a murine monoclonal antibody, LISA 101, selected by reversed indirect enzyme-linked immunosorbent assay.
    Kohno N; Kyoizumi S; Tanabe M; Oyama T; Vossler M; Yamakido M; Akiyama M
    Cancer Res; 1989 Jun; 49(12):3412-9. PubMed ID: 2655895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing fucosyl or sialyl-fucosyl type 2 chain polylactosamine.
    Kannagi R; Fukushi Y; Tachikawa T; Noda A; Shin S; Shigeta K; Hiraiwa N; Fukuda Y; Inamoto T; Hakomori S
    Cancer Res; 1986 May; 46(5):2619-26. PubMed ID: 3008996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis.
    Kohno N
    J Med Invest; 1999 Aug; 46(3-4):151-8. PubMed ID: 10687309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and application of a double- antibody sandwich ELISA kit for the detection of serum MUC1 in lung cancer patients.
    Wang J; Zhang S; Ni W; Zhai X; Xie F; Yuan H; Gao S; Tai G
    Cancer Biomark; 2016; 17(4):369-376. PubMed ID: 27636855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of sialyl-Lewis x on MUC5AC and MUC1 mucins in pancreatic cancer tissues.
    Balmaña M; Duran A; Gomes C; Llop E; López-Martos R; Ortiz MR; Barrabés S; Reis CA; Peracaula R
    Int J Biol Macromol; 2018 Jun; 112():33-45. PubMed ID: 29408556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sialyl Lewis antigens: association with MUC5AC protein and correlation with post-operative recurrence of non-small cell lung cancer.
    Yu CJ; Shih JY; Lee YC; Shun CT; Yuan A; Yang PC
    Lung Cancer; 2005 Jan; 47(1):59-67. PubMed ID: 15603855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing epitopes consisting of sialyl or sialyl-fucosyl type 1 chain.
    Kannagi R; Kitahara A; Itai S; Zenita K; Shigeta K; Tachikawa T; Noda A; Hirano H; Abe M; Shin S
    Cancer Res; 1988 Jul; 48(13):3856-63. PubMed ID: 2454154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated serum level of sialylated glycoprotein KL-6 predicts a poor prognosis in patients with non-small cell lung cancer treated with gefitinib.
    Fujiwara Y; Kiura K; Toyooka S; Hotta K; Tabata M; Takigawa N; Soh J; Tanimoto Y; Kanehiro A; Kato K; Date H; Tanimoto M
    Lung Cancer; 2008 Jan; 59(1):81-7. PubMed ID: 17765355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.